Effect of Vitamin E on Oxidative Stress Level in Blood, Synovial Fluid, and Synovial Tissue in Severe Knee Osteoarthritis: a Randomized Controlled Study

Overview

Journal BMC Musculoskelet Disord

Publisher Biomed Central

Specialties Orthopedics
Physiology

Date 2017 Jul 1

PMID 28662656

Citations 16

Authors

Saran Tantavisut

Aree Tanavalee

Sittisak Honsawek

Tanyawan Suantawee

Srihatach Ngarmukos

Sirichai Adisakwatana

John J Callaghan

Affiliations

Soon will be listed here.

Abstract

Background: This study was performed to evaluate the antioxidative and anti-inflammatory effects of vitamin E on oxidative stress in the plasma, synovial fluid, and synovial tissue of patients with knee osteoarthritis.

Methods: Seventy-two patients with late-stage knee osteoarthritis scheduled for total knee arthroplasty were randomized to take oral placebo (Group A) or 400 IU of vitamin E (Group B) once a day for 2 months before undergoing surgery. The blood levels of endpoints indicating oxidative stress or antioxidant capacity, Knee Society Score (KSS), Western Ontario and McMaster Universities Osteoarthritis Index score (WOMAC), and adverse effects were compared before and after the intervention between the two groups. At surgery, these redox endpoints and histological findings were compared between the synovial fluid and synovial tissue.

Results: In blood samples, the pre-intervention of oxidative stress and antioxidative capacity were not different between Group A and Group B. In post-intervention blood samples, the Malondialdehyde (Group A 1.34 ± 0.10, Group B 1.00 ± 0.09, p < 0.02), Alpha tocopherol (Group A 15.92 ± 1.08, Group B 24.65 ± 1.47, p < 0.01) and Trolox equivalent antioxidant capacity (Group A 4.22 ± 0.10, Group B 5.04 ± 0.10, 0 < 0.01) were significantly different between Group A and Group B. In synovial fluid samples, the Malondialdehyde (Group A 1.42 ± 0.12, Group B 1.06 ± 1.08, p 0.01), Alphatocopherol (Group A 4.51, Group B 7.03, p < 0.01), Trolox equivalent antioxidant capacity (Group A, 1.89 ± 0.06, Group B 2.19 ± 0.10) were significantly different between Group A and Group B. The pre-intervention WOMAC score and KSS score were not different between Group A and Group B. The post-intervention WOMAC score was significantly improved in all categories in Group B (Pain: Group A 27.26 ± 0.89, Group B 19.19 ± 1.43, p < 0.01; Stiffness: Group A 8.23 ± 0.79, Group B 5.45 ± 0.73, p 0.01; Function: Group A 94.77 ± 4.22, Group B 72.74 ± 6.55, p < 0.01). The post-intervention KSS score was significantly improved in all categories in Group B (Clinical: Group A 25.31 ± 14.33, Group B 33.52 ± 16.96, p < 0.01; Functional: Group A 41.43 ± 16.11, Group B 51.61 ± 19.60, p 0.02). Significantly fewer synovial tissue cells were stained with nitrotyrosine and hematoxylin-eosin in Group B than in Group A. There were no differences in adverse effects or surgical complications between the groups.

Conclusion: Vitamin E is an effective antioxidant that can improve clinical symptoms and reduce oxidative stress conditions in patients with late-stage knee osteoarthritis.

Trial Registration: This research project had been approved for registration at Thai Clinical Trials Registry (TCTR) since 2016-08-28 11:26:32 (Retrospective registered). The TCTR identification number is TCTR20160828001 .

Citing Articles

No genetic causal association between circulating alpha-tocopherol levels and osteoarthritis, a two-sample Mendelian randomization analysis.

Cui A, Xiao P, Wang P, Wang H, Cong Y, Fan Z Sci Rep. 2024; 14(1):10099.

PMID: 38698019 PMC: 11066079. DOI: 10.1038/s41598-024-60676-5.

Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis.

Zhang X, Hou L, Guo Z, Wang G, Xu J, Zheng Z Cell Death Discov. 2023; 9(1):320.

PMID: 37644030 PMC: 10465515. DOI: 10.1038/s41420-023-01613-9.

A blinded, placebo-controlled study on the clinical effects of vitamin E supplementation in dogs with osteoarthritis.

Gordon C, Reeves S, Burchell R, Thomson C, Gal A, Lopez-Villalobos N J Vet Intern Med. 2023; 37(5):1839-1847.

PMID: 37522795 PMC: 10472994. DOI: 10.1111/jvim.16816.

Age and Sex Differences in the Association between Serum Vitamin E Levels and Depressive Symptoms: Korea National Health and Nutrition Examination Survey.

Jeong H, Oh J, Son N, Lee S Nutrients. 2023; 15(8).

PMID: 37111134 PMC: 10144124. DOI: 10.3390/nu15081915.

Ferroptosis Plays a Role in Human Chondrocyte of Osteoarthritis Induced by IL-1β .

Xu W, Zhang B, Xi C, Qin Y, Lin X, Wang B Cartilage. 2023; 14(4):455-466.

PMID: 36786219 PMC: 10807732. DOI: 10.1177/19476035221142011.

References

Kellgren J, Lawrence J . Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16(4):494-502. PMC: 1006995. DOI: 10.1136/ard.16.4.494. View

Sarban S, Kocyigit A, Yazar M, Isikan U . Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem. 2005; 38(11):981-6. DOI: 10.1016/j.clinbiochem.2005.08.003. View

Bhattacharya I, Saxena R, Gupta V . Efficacy of vitamin E in knee osteoarthritis management of North Indian geriatric population. Ther Adv Musculoskelet Dis. 2012; 4(1):11-9. PMC: 3383525. DOI: 10.1177/1759720X11424458. View

Jang D, Murrell G . Nitric oxide in arthritis. Free Radic Biol Med. 1998; 24(9):1511-9. DOI: 10.1016/s0891-5849(97)00459-0. View

Nelson A, Allen K, Golightly Y, Goode A, Jordan J . A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum. 2014; 43(6):701-12. DOI: 10.1016/j.semarthrit.2013.11.012. View

Sandhu J, Robertson S, Birnboim H, Goldstein R . Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 2003; 30(6):1173-81. View

Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I . Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 1998; 41(12):2165-74. DOI: 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O. View

Suantawee T, Tantavisut S, Adisakwattana S, Tanavalee A, Yuktanandana P, Anomasiri W . Oxidative stress, vitamin e, and antioxidant capacity in knee osteoarthritis. J Clin Diagn Res. 2013; 7(9):1855-9. PMC: 3809620. DOI: 10.7860/JCDR/2013/5802.3333. View

Merzouk S, Hichami A, Madani S, Merzouk H, Berrouiguet A, Prost J . Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys. 2003; 22(1):15-27. View

10.

Zhang W, Nuki G, Moskowitz R, Abramson S, Altman R, Arden N . OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010; 18(4):476-99. DOI: 10.1016/j.joca.2010.01.013. View

11.

Kuptniratsaikul V, Rattanachaiyanont M . Validation of a modified Thai version of the Western Ontario and McMaster (WOMAC) osteoarthritis index for knee osteoarthritis. Clin Rheumatol. 2007; 26(10):1641-5. DOI: 10.1007/s10067-007-0560-y. View

12.

Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K . Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986; 29(8):1039-49. DOI: 10.1002/art.1780290816. View

13.

Lien E, Ren S, Bui H, Wang R . Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic Biol Med. 1999; 26(3-4):285-94. DOI: 10.1016/s0891-5849(98)00190-7. View

14.

Tam L, Li E, Leung V, Griffith J, Benzie I, Lim P . Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol. 2005; 32(2):275-82. View

15.

Madhujith T, Izydorczyk M, Shahidi F . Antioxidant properties of pearled barley fractions. J Agric Food Chem. 2006; 54(9):3283-9. DOI: 10.1021/jf0527504. View

16.

Wieland H, Michaelis M, Kirschbaum B, Rudolphi K . Osteoarthritis - an untreatable disease?. Nat Rev Drug Discov. 2005; 4(4):331-44. DOI: 10.1038/nrd1693. View

17.

Karan A, Karan M, Vural P, Erten N, Tascioglu C, Aksoy C . Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin Rheumatol. 2003; 22(6):397-9. DOI: 10.1007/s10067-003-0761-y. View

18.

Ersoy Y, Ozerol E, Baysal O, Temel I, MacWalter R, Meral U . Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Ann Rheum Dis. 2002; 61(1):76-8. PMC: 1753884. DOI: 10.1136/ard.61.1.76. View

19.

McAlindon T, Jacques P, Zhang Y, Hannan M, Aliabadi P, Weissman B . Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?. Arthritis Rheum. 1996; 39(4):648-56. DOI: 10.1002/art.1780390417. View

20.

Martel-Pelletier J . Pathophysiology of osteoarthritis. Osteoarthritis Cartilage. 1999; 7(4):371-3. DOI: 10.1053/joca.1998.0214. View